Kamrine E Poels
Kamrine E Poels
1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA USA
2Department of Data Science, Dana Farber Cancer Institute, Boston, MA USA
1,2,
Adam J Schoenfeld
Adam J Schoenfeld
3Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY USA
3,
Alex Makhnin
Alex Makhnin
3Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY USA
3,
Yosef Tobi
Yosef Tobi
3Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY USA
3,
Yuli Wang
Yuli Wang
4Oncology Research and Development, Pfizer Inc, La Jolla, CA USA
4,
Heidie Frisco-Cabanos
Heidie Frisco-Cabanos
5Massachusetts General Hospital Cancer Center, Boston, MA USA
5,
Shaon Chakrabarti
Shaon Chakrabarti
1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA USA
2Department of Data Science, Dana Farber Cancer Institute, Boston, MA USA
6Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA USA
1,2,6,
Manli Shi
Manli Shi
4Oncology Research and Development, Pfizer Inc, La Jolla, CA USA
4,
Chelsi Napoli
Chelsi Napoli
5Massachusetts General Hospital Cancer Center, Boston, MA USA
5,
Thomas O McDonald
Thomas O McDonald
1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA USA
2Department of Data Science, Dana Farber Cancer Institute, Boston, MA USA
6Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA USA
7The Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA USA
1,2,6,7,
Weiwei Tan
Weiwei Tan
8Clinical Pharmacology Oncology, Global Product Development, Pfizer Inc, San Diego, CA USA
8,
Aaron Hata
Aaron Hata
5Massachusetts General Hospital Cancer Center, Boston, MA USA
9The Ludwig Center at Harvard, Boston, MA USA
10Department of Medicine, Harvard Medical School, Boston, MA USA
5,9,10,
Scott L Weinrich
Scott L Weinrich
4Oncology Research and Development, Pfizer Inc, La Jolla, CA USA
4,
Helena A Yu
Helena A Yu
3Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY USA
3,✉,
Franziska Michor
Franziska Michor
1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA USA
2Department of Data Science, Dana Farber Cancer Institute, Boston, MA USA
6Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA USA
7The Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA USA
9The Ludwig Center at Harvard, Boston, MA USA
11The Broad Institute of MIT and Harvard, Cambridge, MA USA
1,2,6,7,9,11,✉
1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA USA
2Department of Data Science, Dana Farber Cancer Institute, Boston, MA USA
3Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY USA
4Oncology Research and Development, Pfizer Inc, La Jolla, CA USA
5Massachusetts General Hospital Cancer Center, Boston, MA USA
6Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA USA
7The Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA USA
8Clinical Pharmacology Oncology, Global Product Development, Pfizer Inc, San Diego, CA USA
9The Ludwig Center at Harvard, Boston, MA USA
10Department of Medicine, Harvard Medical School, Boston, MA USA
11The Broad Institute of MIT and Harvard, Cambridge, MA USA
Subject terms: Cancer therapy, Applied mathematics
© The Author(s) 2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
